In the US, Deferiprone (deferiprone systemic) is a member of the following drug classes: antidotes, chelating agents and is used to treat Hemosiderosis, Iron Overload, Superficial Siderosis and Thalassemia.
ATC (Anatomical Therapeutic Chemical Classification)
CAS registry number (Chemical Abstracts Service)
- Deferipronum (Latin)
- Deferipron (German)
- Défériprone (French)
- Deferiprona (Spanish)
- Deferiprone (OS: BAN, USAN)
- Défériprone (OS: DCF)
- Chelfer (IS)
- L1 (IS)
ApoPharma, United States; Apotex, Czech Republic; Apotex, Greece; Apotex, Hong Kong; Apotex, Israel; Apotex, Lithuania; Apotex, Norway; Apotex, Oman; Apotex, Philippines; Apotex, Poland; Apotex, Portugal; Apotex, Romania; Apotex, Singapore; Apotex, Thailand; Apotex, Tunisia; Apotex Europe, Austria; Apotex Europe, Cyprus; Apotex Europe-NL, Italy; Aspen, New Zealand; Chiesi, Turkey; Nordic, Switzerland; Orphan, Australia; Pharma Logistics, Belgium; Purissimus, Argentina; Quamed/Apotex, Indonesia; SOBI, Sweden; Swedish Orphan, Germany; Swedish Orphan, Denmark; Swedish Orphan, Spain; Swedish Orphan Biovitrum, Finland; Swedish Orphan Biovitrum, France; Swedish Orphan Biovitrum, United Kingdom; Swedish Orphan Biovitrum Ltd., Ireland
Cipla, Thailand; Cipla, Taiwan
|BAN||British Approved Name|
|DCF||Dénomination Commune Française|
|Rec.INN||Recommended International Nonproprietary Name (World Health Organization)|
|USAN||United States Adopted Name|
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.